Inactive Instrument

Wayland Group Corp Stock price Canadian Securities Exchange

Equities

CA5667241007

Pharmaceuticals

Sales 2016 4.06 5.5 Sales 2017 3.22 4.37 Capitalization 203M 275M
Net income 2016 -8M -10.84M Net income 2017 -67M -90.79M EV / Sales 2016 * -
Net Debt 2016 9.13 12.37 Net cash position 2017 0.42 0.57 EV / Sales 2017 63,046,727 x
P/E ratio 2016 *
-
P/E ratio 2017
-2.13 x
Employees -
Yield 2016 *
-
Yield 2017
-
Free-Float 100%
More Fundamentals * Assessed data
Dynamic Chart
RG5 Investments Inc. and Albert Sheeler cancelled the acquisition of Gardina Pharmaceutical SAS from Wayland Group Corp.. CI
Wayland Group Corp. Announces Board and CEO Resignation CI
CanAdelaar B.V. completed the acquisition of Maricann Inc. and certain certain other property from Wayland Group Corp. and Nanoleaf Technologies Inc. CI
CanAdelaar B.V. agreed to acquire Maricann Inc. and certain certain other property from Wayland Group Corp. and Nanoleaf Technologies Inc. for CAD 12.4 million. CI
RG5 Investments Inc. and Albert Sheeler agreed to acquire Gardina Pharmaceutical SAS from Wayland Group Corp. for CAD 0.3 million. CI
Wayland Group Corp. Announces Management Changes CI
Wayland Announces Court Approval of Amended DIP Facility CI
Wayland Group cancelled the acquisition of 97% stake in Agro Ivica Dumandzic S.R.L. CI
Maricann Group Inc. cancelled the acquisition of 51% stake in Theros Pharma Ltd. CI
Wayland Group Corp. cancelled the acquisition of 50.1% stake in Tropicana Pty Ltd. CI
ICC International Cannabis Corp. (CNSX:WRLD.U) cancelled the acquisition of 49.9% stake in Maricann B.V. from Wayland Group Corp.. CI
Maricann Group Inc. cancelled the acquisition of Colma Pharmaceutical SAS on November 6, 2019. CI
Wayland Group Corp. Provides Corporate Update on Transaction, Construction and Operational Progress; Revises Revenue Guidance for 2019; Plans to Plan New Plants CI
Wayland Group Receives $5 Million Bridge Loan from Cryptologic CI
Wayland Group Corp. Announces Executive Changes CI
More news
Managers TitleAgeSince
Chief Executive Officer 44 -
Chief Operating Officer - -
Chief Tech/Sci/R&D Officer - -
Members of the board TitleAgeSince
Chief Executive Officer 44 -
More insiders
Wayland Group Corp, formerly Maricann Group Inc, is a Canada-based vertically integrated cultivator and processor of cannabis. The Company has production facilities in Langton, Ontario where it operates a cannabis cultivation, extraction, formulation, and distribution business under federal licenses from the Government of Canada. The Company also has production operations in Dresden, Saxony, Germany, Regensdorf, Switzerland, Allesandria, Piedmont, Italy and Ibague, Colombia.
More about the company
  1. Stock
  2. Equities
  3. Stock Wayland Group Corp.
  4. Stock Wayland Group Corp - Canadian Securities Exchange